Treatment with obinutuzumab plus venetoclax reshapes the TRB repertoire of CLL patients

Treatment with obinutuzumab plus venetoclax reshapes the TRB repertoire of CLL patients

Saved in:

Bibliographic Details
Main Authors:	Paul J. Hengeveld, Joyce Schilperoord-Vermeulen, P. Martijn Kolijn, Julie M. N. Dubois, Peter E. Westerweel, Sabina Kersting, Arnon P. Kater, Mark-David Levin, Anton W. Langerak
Format:	Article
Language:	English
Published:	Nature Publishing Group 2025-01-01
Series:	Blood Cancer Journal
Online Access:	https://doi.org/10.1038/s41408-025-01209-9
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Longitudinal omics data and preclinical treatment suggest the proteasome inhibitor carfilzomib as therapy for ibrutinib-resistant CLL
by: Lavinia Arseni, et al.
Published: (2025-01-01)

Efficacy, safety and cost-effectiveness of obinutuzumab in patients with follicular lymphoma: a rapid review
by: Chao Wang, et al.
Published: (2025-01-01)

Basic Principles for Elaboration of Technical Requirements to Control and Protective TRB Turbine Systems
by: N. V. Panteley
Published: (2007-08-01)

Proliferating CLL cells express high levels of CXCR4 and CD5
by: Daniel Friedman, et al.
Published: (2024-12-01)

Myelodysplastic Syndrome with Transfusion Dependence Treated with Venetoclax
by: Waqas Jehangir, et al.
Published: (2020-01-01)

Squamate reptiles may have compensated for the lack of γδTCR with a duplication of the TRB locus
by: Jordan M. Sampson, et al.
Published: (2025-01-01)

Analysis of the Misconceptions Taking Accounting Education Students About Accounting Education: Example of TRB 1 Region
by: Özcan Demir, et al.
Published: (2024-12-01)

Myeloid Disease with the CSF3R T618I Mutation after CLL
by: Maria Eduarda Couto, et al.
Published: (2020-01-01)

Human TCR repertoire in cancer
by: Lin Chen, et al.
Published: (2024-09-01)

Les répertoires graphiques amazoniens
by: Pierre Déléage
Published: (2007-12-01)

Technical and Economic Advantages of Turbo-Drive Variant with TRB Turbines over Turbo-Generator Variant in Low Power Engineering
by: N. V. Panteley
Published: (2008-04-01)

Venetoclax plus low-intensity chemotherapy for adults with acute lymphoblastic leukemia
by: Marlise R. Luskin, et al.
Published: (2025-02-01)

Valproic Acid Enhances Venetoclax Efficacy in Targeting Acute Myeloid Leukemia
by: Renshi Kawakatsu, et al.
Published: (2025-01-01)

Investigating resistance to 5-Azacytidine and Venetoclax in PDX models of MDS/AML
by: Petra Bašová, et al.
Published: (2025-01-01)

Reshaping the Riparian: Human Mobility and Fixed Infrastructure
by: Craig E. Colten
Published: (2015-03-01)

Assessment of the Diagnostic and Prognostic Values of CD200 and CD43 in CLL and Leukemic Phase of NHL
by: Teeb M. Jaafar Al-Khafaji, et al.
Published: (2024-12-01)

T Cell Repertoire and Inflammatory Bowel Disease
by: Kenneth Croitoru, et al.
Published: (1996-01-01)

La « jeunesse » comme répertoire critique
by: Jeanne Lamaison-Boltanski
Published: (2020-01-01)

NGS Analysis of Clonality and Minimal Residual Disease in a Patient with Concurrent Richter’s Transformation and CLL/SLL
by: Shrihari S. Kadkol, et al.
Published: (2021-01-01)

The role of the CLL-1 protein in disease monitoring in patients diagnosed with acute myeloid leukaemia and myelodysplastic syndrome
by: Ewa Dobak, et al.
Published: (2024-10-01)

THEATRICAL LIFE AND REPERTOIRE OF THE MARIONETTE THEATRE OF ESTERHÁZ
by: Kata ASZTALOS
Published: (2012-06-01)

REPERTOIRE OF CINEMAS AND AUDIENCE PREFERENCES IN THE ERA OF "STAGNATION"
by: M. Kosinova
Published: (2016-06-01)

Sex Hormone Receptor Repertoire in Breast Cancer
by: Gerald M. Higa, et al.
Published: (2013-01-01)

Models for Natural Killer Cell Repertoire Formation
by: Mali Salmon-Divon, et al.
Published: (2003-01-01)

Répertoire de thèses (2006-février 2015)
Published: (2015-02-01)

Répertoire des thèses (2006-juin 2016)
Published: (2016-09-01)

Data Reshaped: Literalism in the Age of Digital Design and Architectural Fabrication
by: Eran Neuman
Published: (2014-11-01)

Back to (the Future) School. Reshaping the Relationship Between Mobility and Schools
by: Fabrizia Cannella, et al.
Published: (2022-12-01)

Harnessing nanoparticles for reshaping tumor immune microenvironment of hepatocellular carcinoma
by: JinSong Li, et al.
Published: (2025-02-01)

Real-life outcome after failure to venetoclax and hypomethylating-based therapy for acute myeloid leukemia
by: Carlos Jiménez-Vicente, et al.
Published: (2025-01-01)

Information seeking behaviour in music conductors’ repertoire selection
by: Christina Firkins, et al.
Published: (2024-06-01)

Le renouvellement du répertoire attique par emprunts
by: Anne Tichit
Published: (2019-12-01)

Mitigating errors in analog quantum simulation by Hamiltonian reshaping or Hamiltonian rescaling
by: Rui-Cheng Guo, et al.
Published: (2025-01-01)

Reshaping Our Understanding of Sensation and Pain Following Breast Reduction Surgery
by: Katya Remy, MD, et al.
Published: (2025-01-01)

AI-powered chatbots reshaping dentistry: Opportunities, challenges, and future directions
by: Vikas V. Pawar, et al.
Published: (2024-03-01)

Venetoclax added to CLAG regimen might improve the outcome of patients with relapsed/refractory acute myeloid leukemia
by: Yu Zhang, et al.
Published: (2025-02-01)

Venetoclax-based salvage therapy as a bridge to transplant is feasible and effective in patients with relapsed/refractory AML
by: Julia M. Unglaub, et al.
Published: (2025-01-01)

Age-Adjusted Schedules of Venetoclax and Hypomethylating Agents to Treat Extremely Elderly Patients with Acute Myeloid Leukemia
by: Aaron M. Lee, et al.
Published: (2022-01-01)

Single-center experience of venetoclax combined with azacitidine in young patients with newly diagnosed acute myeloid leukemia
by: Xuezhu Xu, et al.
Published: (2025-01-01)

Exploring BCL2 regulation and upstream signaling transduction in venetoclax resistance in multiple myeloma: potential avenues for therapeutic intervention
by: Rodrigo Fonseca, et al.
Published: (2025-02-01)